People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Voltron Therapeutics, Inc. | — | Biotechnology | Seed | $9.4M | $39.3M | 2019 |
| PD Theranostics, Inc. | — | Biotechnology | Pre-Seed | $508K | $5.6M | 2022 |
| Ppll Partners, Llc | — | Other | Pre-Seed | $305K | $7.0M | 2018 |
Matthew Eitner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Eitner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gallagher | 2 | 11 |
| Matthew Duffy | 2 | 5 |
| James Ahern | 2 | 4 |
| Anthony Zook | 1 | 4 |
| Paul Korner | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.